Effects of the insurmountable angiotensin AT 1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts

By Wang Q.-D.   Sjoquist P.-O.  

European Journal of Pharmacology, Vol. 380, Iss. 1, 1999-09 ,pp. : 13-21

Elsevier

Access to resources Recommend Favorite

Comparative effects of tamoxifen and angiotensin II type-1 receptor antagonist therapy on the hemodynamic profile of the ovariectomized female rat

By Pham-Dang My-Lan   Clement Robert   Mercier Isabelle   Calderone Angelino  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 9, 2003-09 ,pp. : 915-919

NRC Research Press

Access to resources Recommend Favorite

Valsartan: a novel angiotensin Type 1 receptor antagonist

By Thürmann P.A.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 337-350

Informa Healthcare

Access to resources Recommend Favorite

Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide Combination and its Effect on Plasma B-Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin II Type 1 Receptor Antagonist-Based Therapy: A Multicentre Prospective Observational Study

By Meno Hiroshi  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 171-178

Adis International

Access to resources Recommend Favorite

Angiotensin II-Receptor Antagonist Losartan Does not Prevent Nitroglycerin Tolerance in Patients with Coronary Artery Disease

By Longobardi Giancarlo   Ferrara Nicola   Leosco Dario   Abete Pasquale   Furgi Giuseppe   Cacciatore Francesco   Corbi Graziamaria   Pescatore Raffaella   Rengo Franco  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 363-370

Springer Publishing Company

Access to resources Recommend Favorite